Dr. Nicholas Koroneos, DO, MS

Dr. Koroneos practices at McLeod Regional Medical Center of T - McLeod Cardiology Associates Myrtle Beach - HOPD in Myrtle Beach, South Carolina.

Dr. Koroneos' NPI, 1134622913, was assigned on March 17, 2018. Dr. Koroneos graduated from New York College of Osteo Medicine of New York Institute of Technology in 2018. Dr. Koroneos holds South Carolina license 90056.

Dr. Koroneos' primary practice is McLeod Regional Medical Center of T - McLeod Cardiology Associates Myrtle Beach - HOPD, at 107 McLeod Health Blvd, Myrtle Beach, SC 29579.

Dr. Koroneos' primary practice is McLeod Regional Medical Center of T - McLeod Cardiology Associates Myrtle Beach - HOPD in Myrtle Beach, South Carolina. Dr. Koroneos is also affiliated with MUSC Health University Medical Center. The medical group on file is McLeod Physician Associates. Dmand AI also links Dr. Koroneos to 3 more hospitals, 2 group practices and clinics, 2 home health agencies, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koroneos practices, 10 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Koroneos' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Koroneos is licensed in South Carolina.

CMS data shows 41,121 Medicare services from Dr. Koroneos across 13 procedure codes in 2024, for 515 Medicare patients. Medicare paid $201,622 for them. Every service was in an office.

CMS counts 515 Medicare patients who saw Dr. Koroneos in 2024. The largest group is 65 to 74, with 226 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Koroneos' median patient age at 76, with 57% women.

In 2024, Dr. Koroneos wrote 1,849 Medicare Part D claims for 517 patients. 92% of them were for generic drugs. CMS names the drug for 1,561 of them, across 37 drugs with 11 or more claims each, at $189,797 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Koroneos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Koroneos as offering telehealth. CMS counts 22 procedures of skin biopsy by Dr. Koroneos, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Koroneos, published from 2022 to 2025. 2023 was the busiest year, with 2. Dr. Koroneos has published most often in Case Rep Neurol Med. Dr. Koroneos' most frequent co-authors are Olga Syritsyna, MD, Ryan C. Corn, DO and Agnieszka Katarzyna Kowalska, MD.

CMS Open Payments shows 182 general payments to Dr. Koroneos from 35 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $459.

Dr. Koroneos graduated from New York College of Osteo Medicine of New York Institute of Technology in 2018.